NCT02415036 Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma Status TERMINATED Phase PHASE2
NCT02412579 Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation Status COMPLETED Phase N/A
NCT02400788 Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE1/PHASE2
NCT02399735 Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation Status UNKNOWN Phase PHASE1
NCT02399033 Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy Status UNKNOWN Phase PHASE4
NCT02395523 Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT02358395 A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT02354898 A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT02344680 Liver Fibrosis in Zambian HIV-HBV Co-infected Patients Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02329821 Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection Status COMPLETED Phase N/A
NCT02323360 A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC Status TERMINATED Phase NA
NCT02314052 Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02311205 Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) Status UNKNOWN Phase PHASE2
NCT02309788 Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis Status UNKNOWN Phase N/A
NCT02304289 Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma Status TERMINATED Phase PHASE1